, Tracking Stock Market Picks
Enter Symbol:
Abaxis, Inc. (ABAX) [hlAlert]

up 16.51 %

Abaxis, Inc. (ABAX) rated Underperform by BofA/Merrill

Posted on: Monday,  Feb 25, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Abaxis, Inc. (NASDAQ: ABAX) on 02/25/2013, when the stock price was $42.18. Since then, Abaxis, Inc.
has lost 14.18% of its value until BofA/Merrill rated ABAX Neutral on 11/04/2013, when the price was $36.20.
If you would have followed this BofA/Merrill's recommendation on ABAX, you would have gained 16.51% of your investment in 252 days.

Abaxis, Inc. develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The Company's primary product is a system consisting of a compact 6.9 kilogram analyzer and a series of single-use plastic discs called reagent discs containing all the chemicals required to perform a panel of up to 12 tests. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma using either venous or fingerstick samples.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2014 8:25 AM Sell
as of 12/13/2013
1 Week   
1 Month   
3 Months up  10.55 %
1 YTD up  14.17 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/4/2013 8:25 AM Hold
2/25/2013 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy